SITC is deeply concerned by the announcement from NIH that will cut billions of dollars in indirect costs. We urge the NIH & the new administration to reverse this action to ensure life-saving cancer treatments continue to reach the clinic and patients.

RT @jitcancer: New #JITC article: Unveiling the mechanisms of CEBPD-orchestrated TAM polarization through RGS2/PAR2 pathway and its impact….

RT @JoeYeong: Cant wait to host all our guests and friends to World ImmunoTherapy Council APAC that will be held at @mysgh. @SingHealthSG.@….

Stay current with global #IO standards and discover cutting-edge science at #SITC25 in National Harbor, MD or virtually Nov. 5–9! Translate the latest breakthroughs to patient care with insights from international leaders. Early registration ends Aug. 13:

The 2026 SCION Workshop has award opportunities! Check out our Martin “Mac” Cheever Excellence In Clinical Trial Design Travel Award. Awardees receive reimbursement to support their travel to the 2026 SITC Annual Meeting. Learn more:

Catch the latest cancer #immunotherapy research and updates with the July #JITC Digest! Get key takeaways on launching IO therapies with insights from the SITC Biotech Strategic Meeting at the NYSE. Access panel highlights and expert perspectives!

RT @jitcancer: New #JITC letter: Correspondence on “METTL3 promotes an immunosuppressive microenvironment in bladder cancer via m6A-depende….

RT @MoffittNews: @sitcancer We are looking forward to the 40th Anniversary of SITC. See you in National Harbor for #SITC25!.

Register for our 40th Anniversary Annual Meeting and Pre-Conference Programs. #SITC25 consists of cutting-edge research presentations by experts in the field, oral & poster abstract presentations & ample opportunity for structured & informal discussions.

Late-breaking Abstracts – Clinical Only (LBAs) submissions are now open! Submit your cutting-edge research by Sept. 15, 2025. Additional oral presentation opportunities available! #immunotherapy

RT @TheCancerLetter: .@theNCI, @sitcancer immunotherapy fellowship calls for applications.

The SITC Winter School Program is an exciting learning opportunity within the IO field! Register to understand the fundamentals of how the immune system enables #cancer #immunotherapy. Held in Boston, MA or virtually:

Spring Scientific: Enhancing Cellular Therapies with Next-generation IO Molecules will be on March 25-27! Experts in cell therapy, drug development & #IO will address combining next-generation IO agents with cellular therapies to treat cancer. Learn more:

Dedicated to #makingcureareality? Join SITC’s vibrant and growing network of research and physician scientists, clinicians, patients, patient advocates, government representatives and industry leaders. Learn more about #SITC: #immunotherapy

The SITC family is heart-broken to learn of the passing of Dr. Zelig Eshhar. His research in CAR T-cell therapy changed the treatment of cancer. SITC was fortunate to recognize Dr. Eshhar’s ground-breaking work in #IO by inducting him into the FAIO.

There is still time to apply for the 2026 SCION Workshop, held Feb. 16–18, 2026 in Boston, MA! Led by experts in the field who are equipped to help navigate through the unique considerations that accompany immunotherapy treatments. Apply by Aug. 7:

The Primer on Tumor Immunology and Cancer Immunotherapy™ will take place on Nov. 6, 2025 as part of SITC 2025. Organizers: Andrea Schietinger, PhD - Memorial Sloan Kettering Cancer Center & Eric L. Smith, MD, PhD - Dana-Farber Cancer Institute. Register:

#SITC25 Science Preview: Uncover age-related changes in the TME with @dwainwright_PhD @LoyolaChicago, Ashani Weeraratna, PhD @JohnsHopkins, @FaneMitchell @FoxChaseCancer, @sastewartlab @WashU and Amaya Viros, MD, PhD @OfficialUoM. View session details:

Registration is now open for #SITC Winter School 2026! Learn about the core principles of tumor immunology & #cancer #immunotherapy. Experience opportunities to discuss recent advancements in drug and biomarker technologies and their clinical application.

The @sitcancer is fostering the next generation of #IO leaders through global collaboration! Join the conversation with emerging researchers shaping the next wave of IO at the WIC Asia-Pacific Conference, July 21–22, 2025, in Singapore! . Learn more:

View emerging data from ongoing trials of new IO-based approaches to treat hematologic malignancies! Access the most recent cancer IO updates at @sitcancer’s #virtual ACI: A Focus on Hematologic Malignancies program Aug. 25. View topics: @JoshuaRichterMD